Switch to:
More From Other Websites
NEURALSTEM, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 30 2014
Neuralstem Added To Russell 3000 Index Jun 30 2014
Neuralstem, Inc. (CUR): NSI-189: What You Need To Know Jun 26 2014
An Early Valuation Of Neuralstem's NSI-189 For MDD Jun 26 2014
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder Jun 25 2014
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress Jun 19 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events Jun 18 2014
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical... Jun 18 2014
Neuralstem, Inc. – "The FDA is Not the Enemy" Jun 09 2014
Neuralstem, Inc. – "Most men would rather deny a hard truth than face it" May 28 2014
Neuralstem NSI-189 Abstract Teases At Potential Greatness May 28 2014
Neuralstem price target raised to $6 from $4.50 at Aegis May 27 2014
NEURALSTEM, INC. Files SEC form 8-K, Other Events May 23 2014
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical... May 23 2014
NEURALSTEM, INC. Financials May 16 2014
Neuralstem CEO, Richard Garr, to Present at World Stem Cells & Regenerative Medicine Congress and... May 16 2014
NEURALSTEM, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... May 12 2014
Neuralstem reports Q1 EPS (7c), one estimate (6c) May 12 2014
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update May 12 2014
NEURALSTEM, INC. Files SEC form 10-Q, Quarterly Report May 12 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide